Short-term melatonin treatment improved diabetic nephropathy but did not affect hemorheological changes in diabetic rats

Pharmazie

Volumn 62, Issue 9, 2007, Pages 693-698

  Gumustekin, Mukaddes ^a   Tekmen, I ^a   Guneli, E ^a   Tugyan, K ^a   Topcu, A ^a   Ergonen, A T ^a   Ozdemir, M H ^a   Uysal, N ^a   Bediz, C S ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; MELATONIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD RHEOLOGY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG MECHANISM; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; HISTOPATHOLOGY; KIDNEY; LASER DIFFRACTION; MALE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; RAT; TREATMENT OUTCOME;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; BLOOD GLUCOSE; BLOOD VESSELS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; HEMOGLOBIN A, GLYCOSYLATED; IN SITU NICK-END LABELING; KIDNEY; MALE; MELATONIN; RATS; RATS, WISTAR; RHEOLOGY;

EID: 34848869927     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2007.9.6791     Document Type: Article

References (42)

1. Aydogan S, Yerer MB, Yapislar H (2004) In vitro effects of melatonin on the filterability of erythrocytes in SNP-induced oxidative stress. Clin Hemorheol Microcirc 30: 317-322.
2. Beckman JA, Goldfine AB, Gordon MB, Creager MA (2001) Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans. Circulation 103: 1618-1623.
3. Berker M, Dikmenoglu N, Bozkurt G, Ergonul Z, Ozgen T (2004) Hemorheology, melatonin and pinealectomy. What's the relationship? An experimental study. Clin Hemorheol Microcirc 30: 47-52.
4. Calles-Escandon J, Cipolla M (2001) Diabetes and endothelial dysfunction: a clinical perspective. Endocr Rev 22: 36-52.
5. Cam M, Yavuz O, Guven A, Ercan F, Bukan N, Ustundag N (2003) Protective effects of chronic melatonin treatment against renal injury in streptozotocin-induced diabetic rats. J Pineal Res 35: 212-220.
6. Chung TW, Yu JJ, Liu DZ (1998) Reducing lipid peroxidation stress of erythrocyte membrane by alpha-tocopherol nicotinate plays an important role in improving blood rheological properties in type 2 diabetic patients with retinopathy. Diabet Med 15: 380-385.
7. Cinar MG, Ullker S, Alper G, Evinc A (2001) Effect of dietary vitamin E supplementation on vascular reactivity of thoracic aorta in streptozotocin- diabetic rats. Pharmacology 62: 56-64.
8. Creager MA, Luscher TF, Cosentino F, Beckman JA (2003) Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation 108: 1527-1532.
9. Demiroglu H, Gurlek A, Barista I (1999) Enhanced erythrocyte aggregation in type 2 diabetes with late complications. Exp Clin Endocrinol Diabetes 107: 35-39.
10. Diamantopoulos EJ, Kittas C, Charitos D, Grigoriadou M, Ifanti G, Raptis SA (2004) Impaired erythrocyte deformability precedes vascular changes in experimental diabetes mellitus. Horm Metab Res 36: 142-147.
11. Di Mascio P, Dewez B, Garcia CR (2000) Ghost protein damage by peroxynitrite and its protection by melatonin. Braz J Med Biol Res 33: 11-17.
12. Gocmen C, Secilmis A, Karabal KE, Ertug PU, Onder S, Dikmen A (2000) Effects of vitamin E and sodium selenate on neurogenic and endothelial relaxation of corpus cavernosum in the diabetic mouse. Eur J Pharmacol 398: 93-98.
13. Goulle JP, Lacroix C, Bouige D (2002) Glycated hemoglobin: a useful post-mortem reference marker in determining diabetes. Forensic Sci Int 128: 44-49.
14. Ha H, Yu MR, Kim KH (1999) Melatonin and taurine reduce early glomerulopathy in diabetic rats. Free Radical Biol Med 26: 944-950.
15. Hardeman MR, Dobbe JG, Ince C (2001) The Laser-assisted Optical Rotational Cell Analyzer (LORCA) as red blood cell aggregometer. Clin Hemorheol Microcirc 25: 1-11.
16. Huang SY, Jeng C, Kao SC, Yu JJ, Liu DZ (2004) Improved haemorrheological properties by Ginkgo biloba extract (Egb 761) in type 2 diabetes mellitus complicated with retinopathy. Clin Nutr 23: 615-621.
17. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, Nawata H (2000) High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49: 1939-1945.
18. Jain SK, McVie R, Duett J, Herst JJ (1989) Erythrocyte membrane lipid peroxidation and glycoslyated hemoglobin in diabetes. Diabetes 38: 1539-1543.
19. Jay RH, Jones SL, Hill CH, Richmond W, Viberti GC, Rampling MW, Betteridge DJ (1991) Blood rheology and cardiovascular risk factors in type 1 diabetes: relationship with microalbuminuria. Diabet Med 8: 662-667.
20. Karimungi MG, Joshi BN (1996) Diurnal sensitivity in melatonin-induced hematological changes in the male albino rat. Biol Signals 5: 283-290.
21. Kipiani VA, Katsadze MN, Delibashvili DG, Namoradze MSh, Kipiani NV (2006) Relationship between lipid peroxidation processes, blood vessel wall changes and properties of erythrocyte in pathogenesis of microcirculation disorders during experimental diabetes mellitus. Georgian Med News 130: 97-101.
22. Kowaltowski AJ, Castilho RF, Vercesi AE (2001) Mitochondrial permeability transition and oxidative stress. FEBS Lett 495: 12-15.
23. Kunduzova OR, Escourrou G, Seguelas MH, Delagrance P, De La Farge F, Cambon C, Parini A (2003) Prevention of apoptotic and necrotic cell death, caspase-3 activation and renal dysfunction by melatonin after ischemia/reperfusion. FASEB J 17: 872-874.
24. Le Devehat C, Vimeux M, Khodabandehlou T (2004) Blood rheology in patients with diabetes mellitus. Clin Hemorheol Microcirc 30: 297-300.
25. Medina-Navarro R, Duran-Reyes G, Hicks JJ (1999) Pro-oxidating properties of melatonin in the in vitro interaction with the singlet oxygen. Endocr Res 25: 263-280.
26. Naziroglu M, Simsek M, Kutlu M (2004) Moderate exercise with a dietary vitamin C and E combination protects against streptozotocin-induced oxidative damage to the blood and improves fetal outcomes in pregnant rats. Clin Chem Lab Med 42: 511-517.
27. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404: 787-790.
28. Oktem F, Ozguner F, Yilmaz HR, Uz E, Dundar B (2006) Melatonin reduces urinary excretion of N-acetyl-β-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats. Clin Exp Pharmacol Physiol 33: 95-101.
29. Paskaloglu K, Sener G, Dulger GA (2004) Melatonin treatment protects against diabetes-induced functional and biochemical changes in rat aorta and corpus cavernosum. Eur J Pharmacol 499: 345-354.
30. Riquelme B, Foresto P, D'Arrigo M, Valverde J, Rasia R (2005) A dynamic and stationary rheological study of erythrocytes incubated in a glucose medium. J Biochem Biophys Methods 62: 131-141.
31. Satman I, Yilmaz MT, Bastar I, TURDEP Group (1998): Diabetes Epidemiology Study in Turkey: first step data results. Diabetes 47 (Suppl. 1): A384, 1480.
32. Schwartz RS, Madsen JW, Rybicki AC, Nagel RI (1991) Oxidation of spectrin and deformability defects in diabetic erythrocytes. Diabetes 40: 701-708.
33. Solerte SB, Fioravanti M, Ceratti N, Severgnini S, Locatelli M, Pezza N, Rondanelli M, Trecate L, Balza G, Ferrari E (1997) Retrospective analysis of long-term hemorheologic effects of pentoxyfylline in diabetic patients with angiopathic complications. Acta Diabetol 34: 67-74.
34. Tan DX, Chen LD, Poeggeler B, Manchester LC, Reiter RJ (1993) Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1: 57-60.
35. Tan KC, Chow WS, Ai VH, Metz C, Bucala R, Lam KS (2002) Advanced glycation end products and endothelial dysfunction in type 2 diabetes. Diabetes Care 25: 1055-1059.
36. Tesfaramiam B, Cohen RA (1992) Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol 263: 321-326.
37. Tesoriere L, D'Arpa D, Conti S, Giaccone V, Pintaudi AM, Livrea MA (1999) Melatonin protects human red blood cells from oxidative hemolysis: new insights into the radical-scavenging activity. J Pineal Res 27: 95-105.
38. Tugyan K, Uysal N, Ozdemir D, Sonmez U, Pekcetin C, Erbil G, Sonmez A (2006) Protective effect of melatonin against maternal deprivation-induced acute hippocampal damage in infant rats. Neurosci Lett 398: 145-150.
39. Wolff SP, Dean RT (1987) Glucose autooxidation and protein modification: The role of oxidative glycosylation in diabetes. Biochem J 245: 234-250.
40. Yerer MB, Yapislar H, Aydogan S, Yalcin O, Baskurt O (2004) Lipid peroxidation and deformability of red blood cells in experimental sepsis in rats: The protective effects of melatonin. Clin Hemorheol Microcirc 30: 77-82.
41. Yerer MB, Aydogan S, Yapislar H, Yalcin O, Kuru O, Baskurt O (2003) Melatonin increases glutathione peroxidase activity and deformability of erythrocytes in septic rats. J Pineal Res 35: 138-139.
42. Yoo YM, Yim SV, Jang HY, Lea HZ Hwang GC, Kim JW, Kim SA, Lee HJ, Kim J, Chung JH, Leem KH (2002) Melatonin suppresses NO-induced apoptosis via induction of Bcl-2 expression in PGT-beta immortalized pineal cells. J Pineal Res 33: 146-150.